April 27, 2021
According to the research report titled ‘Global 3d Cell Culture Market 2019-2027’, available with Market Study Report, global 3d cell culture market is projected to record a y-o-y growth rate of 12.32% through 2027.
The growth of global 3d cell culture market is propelled due to the factors like increasing prevalence of cancer, progress achieved by usage of regenerative medicine, and surging demand for organ transplants. Moreover, rise in use of 3D cell culture for drug screening and organ transplants, in consort with evolution of technology are bolstering the market share.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2487288/
However, lack of competent workforce, and incompatibility with analytics technologies are impeding the global 3d cell culture market expansion. Additionally, absence of reliable data for research, and problems faced during the experiments related to 3D cell culture are other major restraints.
Based on application, worldwide 3D cell culture market is divided into cancer, tissue engineering & immunohistochemistry, drug development, and stem cell research among others. While the component range include media, and reagents & consumables.
Moving on to end-user verticals, the industry space is classified into biotechnology & pharmaceutical organizations, research laboratories & institutes, and hospitals & diagnostic centers among others.
Moving on regional outlook, global 3D cell culture marketplace is scrutinized for geographies like North America, Europe, Latin America, Middle East & Africa, and Asia-Pacific.
The report cites that Asia Pacific is poised to lead the overall 3D cell culture industry growth over 2019-2027, owing to the vast populace, improving healthcare infrastructure, and growing awareness regarding the new technologies among the users. International companies are intending to move to Asia-Pacific region owing to new opportunities and unsatisfied demands of patients, generating lucrative prospects in the business scenario.
Major companies in worldwide 3D cell culture marketplace include Becton Dickinson and Company (BD), PromoCell, Corning Inc., Tecan Group Ltd., 3D Biotek LLC, Merck Group, Nano3D Biosciences Inc., Emulate Inc., Thermo Fisher Scientific, Lonza Group AG, InSphero AG, GE Healthcare, VWR International, and Synthecon Inc.